Literature DB >> 10430044

Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform.

L Jacobson1, D Beeson, S Tzartos, A Vincent.   

Abstract

The human muscle acetylcholine receptor (AChR) is an oligomeric membrane protein consisting of (alpha1)2,beta,delta,epsilon subunits in the adult form and (alpha 1)2,beta,gamma,delta in the fetal form. The adult AChR is the target for autoantibodies in myasthenia gravis (MG), and antibodies that block the function of fetal AChR can cross the placenta and paralyse the developing baby causing joint contractures. Monoclonal antibodies (mAbs) raised against purified AChR were characterised previously in terms of binding to five regions, three of which appeared to partially overlap, but the subunit localisation of the regions was not clearly established and they were assumed to be mainly on the immunodominant alpha subunits. We have studied binding of the mAbs to AChR subunit extracellular fragments expressed in E. coli, and to AChRs derived from TE671 cells and from fibroblast cell lines expressing human/Torpedo and Torpedo/mouse hybrid receptors. Using a combination of Western blotting and immunoprecipitation experiments, we demonstrate the subunit specificity of each mAb. The results confirm our previous observations but importantly show that only two of the regions are on the alpha subunit, the three others being on the beta, gamma and delta subunits of human AChR. Thus these mAbs should be useful in studies of AChR subunit expression in normal and diseased tissue, and to define further the binding sites of antibodies in MG patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430044     DOI: 10.1016/s0165-5728(99)00086-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita.

Authors:  S Brownlow; R Webster; R Croxen; M Brydson; B Neville; J P Lin; A Vincent; J Newsom-Davis; D Beeson
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis.

Authors:  Kathryn H Ching; Peter D Burbelo; Richard M Kimball; Lora L Clawson; Andrea M Corse; Michael J Iadarola
Journal:  Neuromuscul Disord       Date:  2010-12-30       Impact factor: 4.296

3.  Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.

Authors:  Hakan Cetin; Richard Webster; Wei Wei Liu; Akiko Nagaishi; Inga Koneczny; Fritz Zimprich; Susan Maxwell; Judith Cossins; David Beeson; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-12       Impact factor: 10.154

4.  Rapsyn facilitates recovery from desensitization in fetal and adult acetylcholine receptors expressed in a muscle cell line.

Authors:  Hakan Cetin; Wei Liu; Jonathan Cheung; Judith Cossins; An Vanhaesebrouck; Susan Maxwell; Angela Vincent; David Beeson; Richard Webster
Journal:  J Physiol       Date:  2019-06-17       Impact factor: 5.182

5.  Mutation analysis of CHRNA1, CHRNB1, CHRND, and RAPSN genes in multiple pterygium syndrome/fetal akinesia patients.

Authors:  Julie Vogt; Benjamin J Harrison; Hayley Spearman; Judy Cossins; Sascha Vermeer; Lambert Naudin ten Cate; Neil V Morgan; David Beeson; Eamonn R Maher
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

6.  IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.

Authors:  Maria Isabel Leite; Saiju Jacob; Stuart Viegas; Judy Cossins; Linda Clover; B Paul Morgan; David Beeson; Nick Willcox; Angela Vincent
Journal:  Brain       Date:  2008-05-31       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.